SPHERA FUNDS MANAGEMENT LTD. 13D/13G Filings for Jasper Therapeutics, Inc. (JSPR)

SPHERA FUNDS MANAGEMENT LTD. 13D and 13G filings for Jasper Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-04
12:05 pm
Sale
2024-09-3013GJASPER THERAPEUTICS INC NE
JSPR
SPHERA FUNDS MANAGEMENT LTD.189,270
1.250%
-6,941,355decrease
(-97.35%)
Filing